Incannex's IHL-42X showed significant efficacy in Phase 2 sleep apnea trial, with strong AHI reduction, improved sleep, and ...

Orfoglipron was associated with improved glycemic control and weight reduction among patients with early-stage type 2 diabetes.

AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

Once-weekly efsitora vs once-daily degludec was associated with comparable glycemic control outcomes and improved patient-reported outcomes.

Bildnachweis: Nasdaq Stockholm, Angelini Ventures, TVM Capital Life Science, FCF, NRW.Bank, VC Magazin, Pixabay. Telling a ...

BioLabs, TUM Venture Labs and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in ...

Hit by rising medical care costs and squeezed by government changes, the health care conglomerate acknowledges “pricing and operational mistakes” affected its bottom line and has outlined steps to ...

In April, Danish drugmaker Novo Nordisk formed what was supposed to be a long-term collaboration to promote its weight-loss ...

A digital asthma self-management program improves asthma control in adults, with greater benefits observed in non-African ...

LTZ Therapeutics, a Sino-American biotech focused on immunotherapy, has announced a strategic research collaboration with US ...